MDBR

The Medical University of South Carolina (MUSC) Hollings Cancer Center has announced the installation of a new cancer-fighting technology, TrueBeam STx.

The advanced cancer treatment system provides patients with a nonsurgical, specialised form of treatment that can be completed in five or even fewer outpatient sessions, each lasting 20 minutes or less.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

MUSC in partnership with national radiosurgery provider Alliance Oncology has invested in the new technology.

The system will be used to treat patients with stereotactic radiosurgery, a non-invasive method of treating tumours with high-dose radiation appropriately matched to the size and shape of the tumour.

TrueBeam STx helps in reducing radiation exposure to healthy tissue as well as enables doctors to provide customised treatment depending on the nature of cancer.

The system is designed to treat cancerous and noncancerous tumours in the body, including the lung, brain, prostate, spine, liver, pancreas, kidney, bone and eye.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData
"TrueBeam STx will allow us to enhance the patient experience by significantly reducing treatment time to five or fewer visits, which will allow patients who receive the treatment to spend more time with their families and to focus on other activities."

In addition, the system can treat certain blood vessel abnormalities, as well as trigeminal neuralgia, a neuropathic disorder that causes intense facial pain.

MUSCHollings Cancer Center Department of Radiation Oncology chairman Joseph Jenrette III said: "TrueBeam STx will allow us to enhance the patient experience by significantly reducing treatment time to five or fewer visits, which will allow patients who receive the treatment to spend more time with their families and to focus on other activities.

"TrueBeam STx can give hope to patients with inoperable or surgically complex tumours, as well as those seeking an alternative to surgery or conventional radiation therapy."

Currently, TrueBeam STx treatments are available at the MUSC Health main campus in downtown Charleston and will be available in Mt. Pleasant in early 2015.


Image: Treatment room at MUSC Health’s Department of Radiation Oncology containing TrueBeam STx technology. Photo: courtesy of PRNewsFoto/MUSC Hollings Cancer Center.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact